270 related articles for article (PubMed ID: 24334872)
1. Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans.
Arsenault BJ; Dubé MP; Brodeur MR; de Oliveira Moraes AB; Lavoie V; Kernaleguen AE; Guauque-Olarte S; Mathieu P; Pibarot P; Messika-Zeitoun D; Bossé Y; Rhainds D; Rhéaume E; Tardif JC
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):457-62. PubMed ID: 24334872
[TBL] [Abstract][Full Text] [Related]
2. High-Density Lipoprotein Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk.
Asztalos BF; Horvath KV; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2007-2015. PubMed ID: 30002062
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol efflux capacity, carotid atherosclerosis, and cerebrovascular symptomatology.
Doonan RJ; Hafiane A; Lai C; Veinot JP; Genest J; Daskalopoulou SS
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):921-6. PubMed ID: 24558111
[TBL] [Abstract][Full Text] [Related]
5. Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels.
Villard EF; EI Khoury P; Frisdal E; Bruckert E; Clement K; Bonnefont-Rousselot D; Bittar R; Le Goff W; Guerin M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):822-8. PubMed ID: 23372063
[TBL] [Abstract][Full Text] [Related]
6. [Smoking, increase in plasma lipoprotein (a) and triglycerides, as well as decrease in plasma HDL-cholesterol concentrations seem to be linked with aortic valve stenosis and its progression].
Swierszcz J; Dubiel JS; Milewicz T; Sztefko K; Krzysiek J
Przegl Lek; 2009; 66(4):159-65. PubMed ID: 19708503
[TBL] [Abstract][Full Text] [Related]
7. Measures of high-density lipoprotein function in men and women with severe aortic stenosis.
Hafiane A; Favari E; Bortnick AE
Lipids Health Dis; 2022 May; 21(1):48. PubMed ID: 35643498
[TBL] [Abstract][Full Text] [Related]
8. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.
Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733
[TBL] [Abstract][Full Text] [Related]
9. Variants at the APOE /C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High-Density Lipoprotein Cholesterol.
Low-Kam C; Rhainds D; Lo KS; Barhdadi A; Boulé M; Alem S; Pedneault-Gagnon V; Rhéaume E; Dubé MP; Busseuil D; Hegele RA; Lettre G; Tardif JC
J Am Heart Assoc; 2018 Aug; 7(16):e009545. PubMed ID: 30369316
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Effects of High-Density Lipoproteins on Acquired von Willebrand Syndrome in Aortic Valve Stenosis.
Gebhard C; Maafi F; Stähli BE; Bonnefoy A; Gebhard CE; Nachar W; de Oliveira Moraes AB; Mecteau M; Mihalache-Avram T; Lavoie V; Kernaleguen AE; Shi Y; Busseuil D; Chabot-Blanchet M; Perrault LP; Rhainds D; Rhéaume E; Tardif JC
Thromb Haemost; 2018 Feb; 118(2):288-297. PubMed ID: 29443370
[TBL] [Abstract][Full Text] [Related]
11. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Association Study Identifies a Functional
León-Mimila P; Villamil-Ramírez H; Macías-Kauffer LR; Jacobo-Albavera L; López-Contreras BE; Posadas-Sánchez R; Posadas-Romero C; Romero-Hidalgo S; Morán-Ramos S; Domínguez-Pérez M; Olivares-Arevalo M; López-Montoya P; Nieto-Guerra R; Acuña-Alonzo V; Macín-Pérez G; Barquera-Lozano R; Del-Río-Navarro BE; González-González I; Campos-Pérez F; Gómez-Pérez F; Valdés VJ; Sampieri A; Reyes-García JG; Carrasco-Portugal MDC; Flores-Murrieta FJ; Aguilar-Salinas CA; Vargas-Alarcón G; Shih D; Meikle PJ; Calkin AC; Drew BG; Vaca L; Lusis AJ; Huertas-Vazquez A; Villarreal-Molina T; Canizales-Quinteros S
Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2494-2508. PubMed ID: 34233476
[TBL] [Abstract][Full Text] [Related]
13. Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis.
Trenkwalder T; Nelson CP; Musameh MD; Mordi IR; Kessler T; Pellegrini C; Debiec R; Rheude T; Lazovic V; Zeng L; Martinsson A; Gustav Smith J; Gådin JR; Franco-Cereceda A; Eriksson P; Nielsen JB; Graham SE; Willer CJ; Hveem K; Kastrati A; Braund PS; Palmer CNA; Aracil A; Husser O; Koenig W; Schunkert H; Lang CC; Hengstenberg C; Samani NJ
Int J Cardiol; 2019 Feb; 276():212-217. PubMed ID: 30482443
[TBL] [Abstract][Full Text] [Related]
14. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
[TBL] [Abstract][Full Text] [Related]
15. [Elevated HDL is the main negative risk factor for coronary artery disease in the elderly patient with calcific aortic valve disease].
Bordalo AD; Nobre AL; Dantas M; Cravino J
Rev Port Cardiol; 2012 Jun; 31(6):415-24. PubMed ID: 22609029
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration.
Fauser S; Smailhodzic D; Caramoy A; van de Ven JP; Kirchhof B; Hoyng CB; Klevering BJ; Liakopoulos S; den Hollander AI
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5525-8. PubMed ID: 21613373
[TBL] [Abstract][Full Text] [Related]
17. [Body mass index influence on aortic valve stenosis].
Swierszcz J; Dubiel JS; Krzysiek J; Sztefko K; Galicka-Latała D; Pfitzner R; Podolec P; Wodniecki J
Przegl Lek; 2011; 68(2):87-91. PubMed ID: 21751516
[TBL] [Abstract][Full Text] [Related]
18. The relation between homocysteine and calcific aortic valve stenosis.
Gunduz H; Arinc H; Tamer A; Akdemir R; Ozhan H; Binak E; Uyan C
Cardiology; 2005; 103(4):207-11. PubMed ID: 15838165
[TBL] [Abstract][Full Text] [Related]
19. Lipid profile of patients with aortic stenosis might be predictive of rate of progression.
Yilmaz MB; Guray U; Guray Y; Cihan G; Caldir V; Cay S; Kisacik HL; Korkmaz S
Am Heart J; 2004 May; 147(5):915-8. PubMed ID: 15131551
[TBL] [Abstract][Full Text] [Related]
20. ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity.
Luo M; Liu A; Wang S; Wang T; Hu D; Wu S; Peng D
Sci Rep; 2017 May; 7(1):2312. PubMed ID: 28539597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
